Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HPC Systems Inc. is a Japanese technology company specializing in high-performance computing (HPC) solutions for scientific research, with a strong focus on the life sciences and drug discovery sectors. The company provides integrated systems that combine high-speed hardware clusters with specialized software for computational chemistry, molecular dynamics, and bioinformatics. Their offerings include the 'HPC Cloud' service, which allows researchers to access massive computing power for virtual screening and lead optimization without maintaining on-site infrastructure. By optimizing the interaction between hardware and scientific algorithms, HPC Systems helps pharmaceutical companies and academic institutions significantly reduce the time required for early-stage drug development. The company is a key player in the Japanese 'Bio-IT' ecosystem and is listed on the Tokyo Stock Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HPC Systems.